Cargando…
Serum lipocalin-2 is a potential biomarker for the clinical diagnosis of nonalcoholic steatohepatitis
BACKGROUND/AIMS: Nonalcoholic steatohepatitis (NASH) is a progressive form of nonalcoholic fatty liver disease (NAFLD) characterized by hepatic steatosis, inflammation, hepatocellular injury, and fibrosis. We aimed to investigate the usefulness of a key biomarker, lipocalin-2 (LCN2), for the detecti...
Autores principales: | Xu, Gang, Wang, Yu-Min, Ying, Miao-Miao, Chen, Sui-Dan, Li, Zong-Rui, Ma, Hong-Lei, Zheng, Ming-Hua, Wu, Jian, Ding, Chunming |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Korean Association for the Study of the Liver
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8046622/ https://www.ncbi.nlm.nih.gov/pubmed/33465844 http://dx.doi.org/10.3350/cmh.2020.0261 |
Ejemplares similares
-
Apoptosis and diagnosis of nonalcoholic steatohepatitis
por: Kim, Chang Wook, et al.
Publicado: (2011) -
Serum Adipokine and Ghrelin Levels in Nonalcoholic Steatohepatitis
por: Yalniz, Mehmet, et al.
Publicado: (2006) -
Higher consumption of animal organ meat is associated with a lower prevalence of nonalcoholic steatohepatitis
por: Zhang, Rui, et al.
Publicado: (2022) -
Diagnostic and interventional circulating biomarkers in nonalcoholic steatohepatitis
por: Tincopa, Monica A.
Publicado: (2020) -
Serum Glycoprotein
Markers in Nonalcoholic Steatohepatitis
and Hepatocellular Carcinoma
por: Ramachandran, Prasanna, et al.
Publicado: (2022)